Corvus Pharmaceuticals Inc CRVSNasdaq
14.73USDClose on 08/11
At a glance
Corvus Pharmaceuticals Inc sits in the ‘Resting’ stage of its cycle. It has moved -31.2% since its first surge signal on 2026-01-20, when the past-year gain stood at +352.6%.
- Since surge signal
- -31.2%
- First surge signal
- 2026-01-20
- Price at signal
- 21.41
- Past-year gain (at signal)
- +352.6%
- Sector
- Biotech
- Market
- US
- As of
- 2026-08-11
Start the AI analysis
No analysis has been run for this ticker today. It takes about a minute.